Risultati per: Benzodiazepine a lunga durata di azione

«Quello che ad un occhio poco attento potrebbe sembrare un semplice accorgimento tecnico – sostiene Silvestro Scotti, segretario generale Fimmg – è invece un intervento legislativo che valorizza migliaia di professionisti (si stima più di 7.000 medici di medicina generale) e avrà un impatto positivo su milioni di cittadini»

Objectives
The aim of this study was to investigate physician benzodiazepine (BZD) self-use pre-COVID-19 pandemic and to examine changes in BZD self-use during the first year of the pandemic.

Design
Population-based retrospective cohort study using linked routinely collected administrative health data comparing the first year of the pandemic to the period before the pandemic.

Setting
Province of Ontario, Canada between March 2016 and March 2021.

Participants

Intervention
Onset of the COVID-19 pandemic in March 2020.

Outcomes measures
The primary outcome measure was the receipt of one or more prescriptions for BZD, which was captured via the Narcotics Monitoring System.

Results
In a cohort of 30 798 physicians (mean age 42, 47.8% women), we found that during the year before the pandemic, 4.4% of physicians had 1 or more BZD prescriptions. Older physicians (6.8% aged 50+ years), female physicians (5.1%) and physicians with a prior mental health (MH) diagnosis (12.4%) were more likely than younger (3.7% aged

Per gli adulti, agisce in 15 minuti su dolore e altri sintomi

Appello da 4 campionesse per praticarlo anche nella terza e quarta età

This Viewpoint discusses complex persistent benzodiazepine dependence and differentiates it from benzodiazepine use disorder.

Objectives
Although chiropractic spinal manipulative therapy (CSMT) and prescription benzodiazepines are common treatments for radicular low back pain (rLBP), no research has examined the relationship between these interventions. We hypothesise that utilisation of CSMT for newly diagnosed rLBP is associated with reduced odds of benzodiazepine prescription through 12 months’ follow-up.

Design
Retrospective cohort study.

Setting
National, multicentre 73-million-patient electronic health records-based network (TriNetX) in the USA, queried on 30 July 2021, yielding data from 2003 to the date of query.

Participants
Adults aged 18–49 with an index diagnosis of rLBP were included. Serious aetiologies of low back pain, structural deformities, alternative neurological lesions and absolute benzodiazepine contraindications were excluded. Patients were assigned to cohorts according to CSMT receipt or absence. Propensity score matching was used to control for covariates that could influence the likelihood of benzodiazepine utilisation.

Outcome measures
The number, percentage and OR of patients receiving a benzodiazepine prescription over 3, 6 and 12 months’ follow-up prematching and postmatching.

Results
After matching, there were 9206 patients (mean (SD) age, 37.6 (8.3) years, 54% male) per cohort. Odds of receiving a benzodiazepine prescription were significantly lower in the CSMT cohort over all follow-up windows prematching and postmatching (p

Comunicato del 17/07/2021 n°52